- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
48
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
48 companies
Takeda Pharmaceutical
Market Cap: JP¥6.7t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,328.00
7D
4.0%
1Y
3.0%
Roche Holding
Market Cap: CHF 238.9b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 288.70
7D
9.4%
1Y
10.0%
Divi's Laboratories
Market Cap: ₹1.7t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹6,539.50
7D
-3.9%
1Y
12.5%
Eurofins Scientific
Market Cap: €10.3b
Provides various analytical testing and laboratory services worldwide.
ERF
€58.74
7D
-1.8%
1Y
29.4%
UCB
Market Cap: €42.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€226.90
7D
4.4%
1Y
24.7%
Elanco Animal Health
Market Cap: US$11.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.86
7D
1.6%
1Y
61.9%
Genmab
Market Cap: DKK 118.1b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,919.00
7D
1.6%
1Y
21.6%
Bayer
Market Cap: €26.0b
Operates as a life science company worldwide.
BAYN
€27.43
7D
2.5%
1Y
31.4%
WuXi Biologics (Cayman)
Market Cap: HK$135.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$33.24
7D
-4.4%
1Y
99.8%
Revvity
Market Cap: US$10.5b
Provides health sciences solutions, technologies, and services.
RVTY
US$94.31
7D
2.9%
1Y
-21.6%
Teva Pharmaceutical Industries
Market Cap: US$28.8b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$25.13
7D
2.2%
1Y
48.3%
BioMarin Pharmaceutical
Market Cap: US$10.1b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.93
7D
4.6%
1Y
-16.9%